TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31375380

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a‐tDCS) at 2 mA for 30 minutes
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study: 30465722

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.15 mg/kg)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 27006178

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus radiotherapy/temozolomide
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 225
Study: 24568258

Group type: EXPERIMENTAL
Intervention: Functional Stabilization Training (FST)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard Training
Number of subjects: 31
Study: 23338260

Group type: EXPERIMENTAL
Intervention: 10% hydrogen peroxide (HP) for 10 min
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: 24% hydrogen peroxide (HP) for 1 min
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Airborne-particle abrasion (Al(2)O(3))
Number of subjects: 52

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 52
Study: 20054294

Group type: EXPERIMENTAL
Intervention: Repaglinide treatment for 8 weeks
Number of subjects: 259

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 259
Study: 18616772

Group type: EXPERIMENTAL
Intervention: Ion-exchange water softeners
Number of subjects: 310
Study: 15578769

Group type: EXPERIMENTAL
Intervention: Tensotin (Julphar, UAE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Tenormin (Zeneca, UK)
Number of subjects: 24
Study: 14609970

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy plus gradual tapering of benzodiazepines (combined treatment)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Gradual tapering of benzodiazepines only (control group)
Number of subjects: 65
Study: 10762517

Group type: EXPERIMENTAL
Intervention: Anticoagulant treatment
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 8618283

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (2 cycles of 70 mg/m² cisplatin and 30 mg/m² doxorubicin with a 3-week interval)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control (no chemotherapy)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 325
Study: 1414144

Group type: EXPERIMENTAL
Intervention: G‐DAMME (0.25 mg iv)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 4022581

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (1% prednisolone acetate) in Group 2
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Systemic prednisone in Group 3
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (Group 1) with cycloplegic and topical antibiotic only
Number of subjects: 75
Study: 31219033

Group type: EXPERIMENTAL
Intervention: Immediate postoperative radiotherapy
Number of subjects: 131

Group type: COMPARATOR
Intervention: Radiotherapy on progression
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Complete resection
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Preoperative involvement of, or operative damage to, the hypothalamus
Number of subjects: 131
Study: 30584418

Group type: EXPERIMENTAL
Intervention: T2T strategy
Number of subjects: 346
Study: 27176121

Group type: EXPERIMENTAL
Intervention: Portable Video Media (PVM)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard Verbal Communication (SVC)
Number of subjects: 72
Study: 24251579

Group type: EXPERIMENTAL
Intervention: Intensive glucose control (addition of an oral glucose-lowering agent or commencement of insulin)
Number of subjects: 11140

Group type: COMPARATOR
Intervention: Standard glucose control
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Addition of an oral glucose-lowering agent
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Commencement of insulin
Number of subjects: 11140
Study: 22189652

Group type: EXPERIMENTAL
Intervention: Circulating-water leg wraps combined with a full-length circulating-water mattress set at 42°C
Number of subjects: 36

Group type: COMPARATOR
Intervention: Forced-air warming system set on high (≈43°C)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Carbon-fiber resistive-heating system set at 42°C
Number of subjects: 36
Study: 20654695

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (12 min)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control condition (movie watching)
Number of subjects: 53
Study: 17931940

Group type: EXPERIMENTAL
Intervention: 17% ethylenediaminetetraacetic acid for 3 minutes
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Cr, Er: YSGG laser treatment for 40 seconds
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no further treatment)
Number of subjects: 52
Study: 16336069

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss program (BWLP)
Number of subjects: 40
Study: 12044126

Group type: EXPERIMENTAL
Intervention: Intranasal cocaine (2 mg/kg of body weight)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (lidocaine, 2 mg/kg)
Number of subjects: 7
Study: 10448262

Group type: EXPERIMENTAL
Intervention: Onapristone 100 mg/day
Number of subjects: 19
Study: 7884433

Group type: EXPERIMENTAL
Intervention: rhIL-3 5 micrograms/kg/d
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: rhIL-3 10 micrograms/kg/d
Number of subjects: 17

Group type: COMPARATOR
Intervention: Carboplatin and cyclophosphamide combination therapy
Number of subjects: 17
Study: 2086422

Group type: EXPERIMENTAL
Intervention: Honan Oculopressor
Number of subjects: 32

Group type: COMPARATOR
Intervention: Suction-cup oculodynamometer
Number of subjects: 32

Group type: COMPARATOR
Intervention: Comparison between Honan Oculopressor and Suction-cup oculodynamometer
Number of subjects: 32

Group type: COMPARATOR
Intervention: Comparison between age groups
Number of subjects: 32
Study: 32961

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 50

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 50
Study: 31652030

Group type: EXPERIMENTAL
Intervention: Simplified language with mediation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Complex text with mediation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simplified language without mediation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Complex text without mediation
Number of subjects: 60
Study: 31172276

Group type: EXPERIMENTAL
Intervention: Pediatric Sleep Questionnaire (PSQ)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: OSA-18
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Logistic regression analyses
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Polysomnography
Number of subjects: 100
Study: 28294535

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Autologous fat
Number of subjects: 62
Study: 25486542

Group type: EXPERIMENTAL
Intervention: Illuminated microcatheter‐assisted trabeculotomy (Group I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combined trabeculotomy with trabeculectomy augmented with mitomycin C (Group II)
Number of subjects: 30
Study: 23895252

Group type: COMPARATOR
Intervention: Cancellous allograft (CAN group)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cancellous allograft mixed with PRP (PRP group)
Number of subjects: 28
Study: 22591551

Group type: EXPERIMENTAL
Intervention: Aquatic biodanza
Number of subjects: 70

Group type: COMPARATOR
Intervention: Stretching exercises
Number of subjects: 70
Study: 19509014

Group type: EXPERIMENTAL
Intervention: PREDIAS group program
Number of subjects: 182

Group type: COMPARATOR
Intervention: Control group (written information about diabetes prevention)
Number of subjects: 182
Study: 17577460

Group type: EXPERIMENTAL
Intervention: Combination therapy with doxazosin and finasteride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Doxazosin monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Finasteride monotherapy
Number of subjects: 0
Study: 15102012

Group type: EXPERIMENTAL
Intervention: Self-monitoring of INR
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Full patient self-management
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Improved patient education
Number of subjects: 163

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 163
Study: 12378041

Group type: EXPERIMENTAL
Intervention: Linseed diet (5% extruded linseed in livestock diet)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard diet (control group)
Number of subjects: 75
Study: 10326113

Group type: EXPERIMENTAL
Intervention: DHF
Number of subjects: 52

Group type: COMPARATOR
Intervention: DF
Number of subjects: 52
Study: 7653825

Group type: EXPERIMENTAL
Intervention: Sevoflurane (n = 21)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Enflurane (n = 20)
Number of subjects: 41
Study: 2551088

Group type: EXPERIMENTAL
Intervention: Prophylactic low-dose heparin/dihydroergotamine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Low-molecular heparin/dihydroergotamine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 7318622

Group type: EXPERIMENTAL
Intervention: Whole-gut irrigation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional mechanical bowel preparation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional preparation
Number of subjects: 100
Study: 31682586

Group type: EXPERIMENTAL
Intervention: Deep learning model based on long short-term memory-based recurrent neural networks for forecasting glucose levels
Number of subjects: 10
Study: 27864724

Group type: EXPERIMENTAL
Intervention: Robotic single-site cholecystectomy (RSSC)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Multiport laparoscopic cholecystectomy (MPLC)
Number of subjects: 136
Study: 25541524

Group type: EXPERIMENTAL
Intervention: Desflurane/remifentanil anesthesia
Number of subjects: 21

Group type: COMPARATOR
Intervention: Propofol/remifentanil anesthesia
Number of subjects: 21
Study: 24032547

Group type: EXPERIMENTAL
Intervention: BAS (titanium-nitride-oxide-coated bioactive stents)
Number of subjects: 827

Group type: COMPARATOR
Intervention: EES (everolimus-eluting stents)
Number of subjects: 827
Study: 21429234

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention group (n = 27)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Close follow-up group (n = 27)
Number of subjects: 54
Study: 19693492

Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 19043994

Group type: EXPERIMENTAL
Intervention: Trauma Risk Management (TRiM) system
Number of subjects: 0
Study: 15231554

Group type: EXPERIMENTAL
Intervention: Short Psychodynamic Supportive Psychotherapy
Number of subjects: 191

Group type: COMPARATOR
Intervention: Combined therapy (psychotherapy + antidepressants)
Number of subjects: 191
Study: 11277173

Group type: EXPERIMENTAL
Intervention: Recombinant human thrombopoietin (rhTPO) administered intravenously by bolus injection at doses ranging from 0.3 to 4.8 microg/kg/day every 3 days and 0.6 microg/kg daily to three patients.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: G-CSF administered concomitantly to promote myeloid recovery.
Number of subjects: 30
Study: 9863499

Group type: EXPERIMENTAL
Intervention: Combination of four virostatics affecting four targets
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combination of three virostatics affecting three targets
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Shorter (3 week) sequences of drug combinations
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CD4 count
Number of subjects: 10
Study: 8307046

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g once daily for two days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Penicillin G standard regimen for six days
Number of subjects: 36
Study: 3721103

Group type: EXPERIMENTAL
Intervention: Ventricular late potentials identified in 28 patients (51%) 4-8 days after MI; mean duration was 75 +/- 33 msec.
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Detection of late potentials showed 75% sensitivity with predictive value of 32%.
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Late potentials longer than 75 msec recorded in all patients who had cardiac death.
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Myocardial dyskinesia present in each patient who developed non-sudden cardiac death.
Number of subjects: 55
Study: 11229783

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31619234

Group type: EXPERIMENTAL
Intervention: Quality of care in rural health facilities
Number of subjects: 377
Study: 30171341

Group type: COMPARATOR
Intervention: Soft laser therapy (15 sessions over 3 weeks)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Shockwave therapy (3 treatments over 3 weeks)
Number of subjects: 61
Study: 27221864

Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: SULT1A1 copy number (3 copies)
Number of subjects: 34
Study: 25444374

Group type: EXPERIMENTAL
Intervention: Focus group discussions and in-depth interviews with community members
Number of subjects: 110
Study: 22133037

Group type: EXPERIMENTAL
Intervention: Sensor-Augmented Pump Therapy (SAPT)
Number of subjects: 485

Group type: COMPARATOR
Intervention: Multiple Daily Injection (MDI) therapy with self-monitoring of blood glucose (SMBG)
Number of subjects: 485
Study: 20438389

Group type: EXPERIMENTAL
Intervention: Intralesional sodium stibogluconate (SSG)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Intralesional 7% hypertonic sodium chloride (HS)
Number of subjects: 154
Study: 17534784

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) for 8 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham training (control group)
Number of subjects: 18
Study: 16172083

Group type: EXPERIMENTAL
Intervention: Writing about betrayal traumas
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Completing an extensive trauma survey
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control conditions (neutral events)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Writing about neutral events
Number of subjects: 99
Study: 12385596

Group type: EXPERIMENTAL
Intervention: 300 mg S-PS daily
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 600 mg S-PS daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 10413268

Group type: EXPERIMENTAL
Intervention: Video demonstration of task perceived as very easy (1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Video demonstration of task perceived as very difficult (2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No video demonstration (3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controllable shooting task at a moving target (1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Uncontrollable shooting task at a moving target (2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition with a reading task (3)
Number of subjects: 0
Study: 7481155

Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thrombolytic treatment (various types)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Streptokinase + Aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Streptokinase + Aspirin + Heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin-accelerated t-PA-heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accelerated t-PA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty
Number of subjects: 0
Study: 2393076

Group type: EXPERIMENTAL
Intervention: Atracurium 0.125 mg/kg after initial dose of Atracurium 0.5 mg/kg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Atracurium 0.125 mg/kg after Alcuronium 0.25 mg/kg
Number of subjects: 14
Study: 6778240

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate inhalation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sodium cromoglycate oral
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31078355

Group type: EXPERIMENTAL
Intervention: High-frequency TENS
Number of subjects: 30
Study: 31604589

Group type: EXPERIMENTAL
Intervention: High density of αSMA+ CAFs
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Increased density of CD86+αSMA+ cells
Number of subjects: 54
Study: 28836470

Group type: EXPERIMENTAL
Intervention: EMLA 5% cream applied daily for 4 weeks as a primary dressing
Number of subjects: 60

Group type: COMPARATOR
Intervention: usual care only
Number of subjects: 60
Study: 26421700

Group type: EXPERIMENTAL
Intervention: Elevation Pillow Group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 100
Study: 23340894

Group type: EXPERIMENTAL
Intervention: IDeg OD Flex (once-daily insulin degludec with 8-40 hour intervals)
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: IDeg OD (once-daily insulin degludec at the main evening meal)
Number of subjects: 687

Group type: COMPARATOR
Intervention: IGlar OD (once-daily insulin glargine at the same time each day)
Number of subjects: 687

Group type: COMPARATOR
Intervention: IDeg OD Flex vs IGlar OD
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: IDeg OD Flex vs IDeg OD
Number of subjects: 687

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 687
Study: 21087125

Group type: EXPERIMENTAL
Intervention: Pocket-sized containers of alcohol-based gel, reminder materials, and education for all healthcare workers (HCWs)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Basic life support education and workshops for all healthcare workers (HCWs)
Number of subjects: 333
Study: 18981188

Group type: EXPERIMENTAL
Intervention: Constraint-Induced Therapy (CIT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional intervention with hand restraint
Number of subjects: 32
Study: 17452906

Group type: EXPERIMENTAL
Intervention: Itraconazole (400 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No itraconazole
Number of subjects: 20
Study: 15335180

Group type: EXPERIMENTAL
Intervention: 5 mg of amlodipine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 20 mg of manidipine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 mg of cilnidipine
Number of subjects: 30
Study: 11218763

Group type: EXPERIMENTAL
Intervention: Intrathecal nicardipine administration (12 ml daily dose, 8 mg of nicardipine for 14 days)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Intrathecal nicardipine administration
Number of subjects: 5
Study: 9052891

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg UID)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nifedipine (60 mg UID)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Verapamil (240 mg BID)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Doxazosin (4 mg UID)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Losartan (50 mg UID)
Number of subjects: 23
Study: 7893227

Group type: EXPERIMENTAL
Intervention: PCR for detection of DNA sequences (65 KDa antigen) of Mycobacterium tuberculosis in CSF samples from test group (10 patients)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (10 patients)
Number of subjects: 20
Study: 3239465

Group type: EXPERIMENTAL
Intervention: Project PRIDE participation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31387441

Group type: EXPERIMENTAL
Intervention: Baseline anemia (n=792)
Number of subjects: 5482
Study: 27754805

Group type: EXPERIMENTAL
Intervention: Testosterone (7.5 g of 1% testosterone gel daily for 3 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (gel)
Number of subjects: 0
Study: 26328600

Group type: EXPERIMENTAL
Intervention: Substitution of 100 g/d sugary drinks with 100 g/d milk
Number of subjects: 366

Group type: COMPARATOR
Intervention: Sugary drink intake
Number of subjects: 366
Study: 22959781

Group type: EXPERIMENTAL
Intervention: Paracalcitol (active vitamin D)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cinacalcet (calcium-sensing receptor agonist)
Number of subjects: 10
Study: 21740765

Group type: EXPERIMENTAL
Intervention: Intensive therapy group
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard treatment group
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Patients with microvascular complications
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Patients with hypoglycemic episodes
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Long disease course
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Higher BMI patients
Number of subjects: 97
Study: 19360440

Group type: EXPERIMENTAL
Intervention: Microscopic assisted percutaneous nucleotomy (MAPN)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard microsurgical discotomy (MC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MAPN
Number of subjects: 100

Group type: COMPARATOR
Intervention: MC
Number of subjects: 100
Study: 16896836

Group type: EXPERIMENTAL
Intervention: 7.5 mg meloxicam for 1 month
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo tablets for 1 month
Number of subjects: 30
Study: 15488340

Group type: EXPERIMENTAL
Intervention: ASI medical composite score
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: ASI psychiatric composite score
Number of subjects: 674
Study: 10655195

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% once daily
Number of subjects: 237

Group type: COMPARATOR
Intervention: Timolol-pilocarpine fixed combination twice daily
Number of subjects: 237

Group type: COMPARATOR
Intervention: Timolol-pilocarpine
Number of subjects: 237
Study: 8862292

Group type: EXPERIMENTAL
Intervention: Lorazepam (30 micrograms/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 1636182

Group type: EXPERIMENTAL
Intervention: Fugl‐Meyer Assessment at baseline
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Fugl‐Meyer Assessment at 5 days
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Fugl‐Meyer Assessment at 30 days
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Sample-size calculations based on severity and time since stroke
Number of subjects: 104